North Carolina Neuropsychiatry, PA Chapel Hill, NC - 919.933.2000
Charlotte, NC - 704.529.4101
Raleigh, NC - 919.785.5055
Set Your Mind Free. Visit NC Neuropsychiatry Today to Learn More

Publications by Gualtieri, C.T.

"Mild Cognitive Disorders"

The following six chapters are draft chapters that will appear, in a year or so, in our new book, Mild Cognitive Disorders. Your comments and recommendations are welcome. You may cite them as you please by referencing our website.

  1. Intro:  Normal Aging, MCI and the Dementias
  1. The Pathology of Normal Aging
  2. The Problem of Dementia
  3. Dementia Screening
  4. MCI Defferential Diagnosis
  5. Dementia Diagnosis
  6. Dementia Prevention & Treatment

Resources for Patients / Frequently Referenced

  • Gualtieri, C.T. (2004). Antidepressant side effects in Children and Adolescents. Download PDF
  • Gualtieri, C.T. (2002). Cognitive enhancers and neuroprotectants. In Brain Injury and Mental Retardation (pp. 429 - 448). Philadelphia, PA: Lippincott Williams & Wilkins. Download PDF

Recent Publications, Presentations, and Research

  • C Thomas Gualtieri MD, Lynda G Johnson, PhD Neurocognition In Depression: Patients On And Off Medication, Compared To Normal Controls. In press - The Journal of Neuropsychiatry and Clinical Neurosciences. Download Abstract (PDF)
  • C Thomas Gualtieri MD, Lynda G Johnson, PhD Differentiating Between Mild Cognitive Impairment And Early Dementia With A New, Computerized Neurocognitive Screening Battery. Alzheimer's Association International Conference on Prevention of Dementia, Washington DC, June, 2005. Download Abstract (PDF)
  • C Thomas Gualtieri MD, Lynda G Johnson, PhD Comparative Neurocognitive Effects of Five Psychotropic Anticonvulsants And Lithium. American Psychiatric Association Annual Meeting, Atlanta, May 26, 2005. Download Abstract (PDF)
  • C Thomas Gualtieri MD, Lynda G Johnson, PhD Neurocognitive Testing Supports a Broader Concept of Mild Cognitive Impairment. American Psychiatric Association Annual Meeting, Atlanta, May 26, 2005. Download Abstract (PDF)
  • Gualtieri, C.T., Johnson, L.G., & Benedict, K.B. Reliability and validity of a new computerized cognitive screening battery. International Neuropsychological Society, Annual Meeting, Baltimore, MD Feb. 4-7, 2004. Download PDF
  • Gualtieri, C.T., Johnson, L.G., & Benedict, K.B. Cognitive performance in bipolar and unipolar depression. International Neuropsychological Society, Annual Meeting, Baltimore, MD Feb. 4-7, 2004. Download PDF
  • Gualtieri, C.T., Johnson, L.G., & Benedict, K.B. Drug sensitivity of a computerized neurocognitive test battery. International Neuropsychological Society, Annual Meeting, Baltimore, MD Feb. 4-7, 2004. Download PDF
  • Gualtieri, C.T., Johnson, L.G., & Benedict, K.B. Psychometric and clinical properties of a new, computerized neurocognitive screening battery. American Neuropsychiatric Association Annual Meeting, Bal Harbor, FL Feb. 24, 2004. Download PDF
  • Gualtieri, C.T., Johnson, L.G., & Benedict, K.B. A Computerized cognitive screening battery for psychiatrists. American Psychiatric Association, Annual Meeting, New York, NY May 2004. Download PDF
  • Gualtieri, C.T., Johnson, L.G., & Benedict, K.B. The comparative neurocognitive effects of seven antidepressants. American Psychiatric Association, Annual Meeting, New York, NY May 2004. Download Abstract (PDF)
  • C Thomas Gualtieri MD, Lynda G Johnson, PhD, Molly Beam BA. Differentiating Between Mild Cognitive Impairment And Early Dementia With A New, Computerized Neurocognitive Screening Battery. 7th International Alzheimer's Association Conference, Philadelphia, 2004. Download Abstract (PDF)
  • Gualtieri, C.T. Computerized neurocognitive test batteries for dementia screening. Alzheimer's Association, 9th International Conference on Alzheimer's Disease and Related Disorders. July 2004. Download PDF
  • Gualtieri, C.T. (2004). Dementia screening in light of the diversity of the condition. Journal of Insurance Medicine. J Insur Med 2004;36:298-309
  • Gualtieri, C.T. (2004). Dementia screening Using Computerized Tests. Journal of Insurance Medicine. J Insur Med 2004;36:213-227

Monographs

  • Gualtieri, C.T. Neuropsychiatry and Behavioral Psychopharmacology. Springer Verlag: Berlin, 1990.
  • Gualtieri, C.T. Mental Retardation. Psychiatric Treatment Manual, Volume 1. American Psychiatric Press, Washington, DC, 1988.
  • Gualtieri, C.T. Neuropsychiatry and the Pharmacology of Behavior. I. The Psychopharmacology of Extraordinary Conditions.
  • Gualtieri, C.T. Neuropsychiatry and the Pharmacology of Behavior. II. The Psychopharmacology of Everyday Life.

AD/HD and Stimulant Drugs

  1. * Gualtieri, C.T., Kanoy, R., Hawk, B., Koriath, U., Schroeder, S.R., Youngblood, W., Breese, G. & Prange, A.J. (1981) Growth hormone and prolactin secretion in adults and hyperactive children: Relation to methylphenidate blood levels. Psycho-neuroendocrinology, 6, 331-339.
  2. Breese, G., Gualtieri, C.T., Mailman, R., Mueller, R., Youngblood, W., Bogel, R. & Wilson, J. (1981) Developmental neuropsychopharmacology: Preclinical and clinical studies of the hyperkinetic syndrome. In: A. Raskin, D. Robinson & J. Levine (Eds), Age and the pharmacology of psychoactive drugs, New York: Elsevier, pp. 63-78.
  3. * Gualtieri, C.T., Wargin, W., Kanoy, R., Shen, C., Patrick, K., Youngblood, W., Mueller, R. & Breese, G. (1982) Clinical Studies of Methylphenidate Serum Levels in Children and Adults. Journal of American Academy of Child Psychiatry, 21, 19-26.
  4. * Gualtieri, C.T., Wargin, W., Kanoy, R., Youngblood, W. & Breese, G. (1982) The effects of eating and fasting on the absorption of methylphenidate. Research Communications in Psychiatry, Psychology & Behavior, 7, 381-384.
  5. * Gualtieri, C.T., Hicks. R.E., Mayo, J.P. (1983) Hyperactivity and Homeostasis. Journal of American Academy of Child Psychiatry, 22, 382-384.
  6. * Wargin, W., Patrick, K., Kilts, C., Gualtieri, C.T., Ellington, K., Mueller, R., Kramer, G. & Breese, G. (1983) Pharmacokinetics of methylphenidate in man, rat and monkey. Journal of Pharmacotherapy and Experimental Therapeutics, 226, 382-386.
  7. * Gualtieri, C.T., Hicks, R.E., Mayo, J.P., Schroeder, S.R. & Lipton, M.A. (1984) The persistence of stimulant effects in chronically treated children: Further evidence of an inverse relationship between drug effects and placebo levels of response. Psychopharmacology, 83, 44-47.
  8. * Gualtieri, C.T., Hicks, R.E., Patrick, K., Schroeder, S.R. & Breese, G.(1984) Clinical correlates of methylphenidate blood levels. Therapeutic Drug Monitoring, 6, 379-392.
  9. * Koriath, U., Gualtieri, C.T., Van Bourgondien, M.E., Quade, D. & Werry, J.S. (1985) Construct Validity of Clinical Diagnosis in Pediatric Psychiatry: Relationship Among Measures. Journal of American Academy of Child Psychiatry, 24(4), 429-436.
  10. Hicks, R.E., Gualtieri, C.T., Mayo, J.P., Schroeder, S.R. & Lipton, M.A. (1985) Methylphenidate and Homeostasis: Drug Effects on the Cognitive Performance of Hyperactive Children. In: L.M. Bloomingdale (Ed), Attention Deficit Disorder II, Identification, Course and Rationale, New York: Spectrum Press, pp. 131-143.
  11. Gualtieri, C.T. & Hicks, R.E. (1985) Stimulants and Neuroleptics in Hyperactive Children (Letter to the Editor). Journal of American Academy of Child Psychiatry, 24(3).
  12. * Gualtieri, C.T., Ondrusek, M.G. 7 Finley, C. (1985) Attention Deficit Disorder in Adults. Clinical Neuropharmacology, 8(4), 343-356.
  13. Gualtieri, C.T. & Hicks, R.E., (1986) The Neuropharmacology of Methylphenidate and a Neural Substrate for Childhood Hyperactivity. Psychiatric Clinics of North America, 8(4), 875-892. Reprinted (1987) in Chess & Thomas (eds) Annual Progress in Child Psychiatry and Child Development.
  14. * Gualtieri, C.T., Hicks, R.E., Levitt, J., Conley, R. & Schroeder, S.R. (1986) Methylphenidate & Exercise: Additive Effects on Motor Performance, Variable Effects on the Neuroendocrine Response. Neuropsychobiology, 15, 84-88.
  15. * Evans, R.W., Amara, I. & Gualtieri, C.T. (1986) Methylphenidate and Memory: Dissociated Effects in Hyperactive Children. Psychopharmacology, 90(2), 211-216.
  16. Evans, R.W., Gualtieri, C.T. & Shear, P.K. (1987) Childhood Hyperactivity. In: B. Epanchin & J. Paul (eds), Emotional Problems of Childhood and Adolescence, Merrill Publishing: Columbus, OH, 143-161.
  17. * Evans, R.W., Gualtieri, C.T. & Hicks, R.E. (1986) Neuropathic Substrate for Stimulant Drug Effects in Hyperactive Children. Clinical Neuropharmacology, 9(3), 264-281.
  18. * Schroeder, S.R., Mann-Koepke, K., Gualtieri, C.T., Eckermann, D.A. & Breese, G.R. (1987) Methylphenidate Affects Strategic Choice Behavior in Normal Adult Humans. Pharmacology, Biochemistry & Behavior, 28, 213-217.
  19. Chandler, M.C. & Gualtieri, C.T. (1988) Other Psychotropic Drugs: Stimulants, Antidepressants, Lithium and the Anxiolytics. In: M.G. Aman (ed), Psychopharmacology of Developmental Disabilities, Springer-Verlag, Berlin.
  20. Patrick, K.S., Mueller, R.A., Gualtieri, C.T. & Breese, G.R. (1988) Pharmacokinetics and Actions of Methylphenidate. In: H. Meltzer, R. Shader & R.Greenblatt (eds) Psychopharmacology: Third Generation of Progress. New York: Raven Press, 1387-1397.
  21. * Chandler, M.C., Barnhill, L.J., Gualtieri, C.T., Patterson, D.R. (1989) Tryptophan Antagonism of Stimulant-Induced Tics. J. Clinical Psychopharmacology, 9(1), p. 69.
  22. * Gualtieri, C.T., P.A. Keenan, and M. Chandler. 1991. Clinical and neuropsychological effects of desipramine in children with attention deficit hyperactivity disorder. J Clin Psychopharmacol 11:155-159.
  23. * Conners,C.K., Casat,C.D., Ascher,J.A., Gualtieri,C.T., Weller,E., Khayrallah,M., Samara,B., Johnston,J.A., Lineberry,C.G.. (1997) Bupropion hydrochloride in attention deficit disorder with hyperactivity, in press.
  24. Jabbour, J.T., Jones, R.C., Bulten, R.G., Harris, R.C., Boehm, R.M., Wilhelm, D.J., Lesser, P.S., Waugh, L.D., Farrell, S.E., Eastmead, D.J., Gualtieri, C.T., Browne, R.G., (1997) Adderall in the Treatment of Attention Deficit Hyperactivity Disorder: A Multi-Center Study, Ms submitted.

Tardive Dyskinesia and Neuroleptic Drugs

  1. * Gualtieri, C.T., Barnhill, L.J., McGimsey, J. & Shell, D. (1980) Tardive dyskinesia and other drug-induced movement disorders in children. Journal of American Academy of Child Psychiatry, 19, 491-510.
  2. * Gualtieri, C.T. & Hawk, B. (1980) Tardive dyskinesia and other drug-induced movement disorders among handicapped children and youth. Journal of Applied Research and Mental Retardation, 1, 55-69. Reprinted (1982) in Chess and Thomas (eds), Annual Progress in Child Psychiatry and Child Development.
  3. * Gualtieri, C.T., Rojahn, J. & Staye, J. (1980) The influence of neuroleptic drugs on prolactin secretion in children. Developmental Medicine and Child Neurology, 23, 255-259.
  4. *Gualtieri, C.T. and Guimond, M. (1981) Tardive dyskinesia and the behavioral consequences of chronic neuroleptic treatment. Developmental Medicine and Child Neurology, 23, 255, 259.
  5. * Gualtieri, C.T., Lefler, W.H., Guimond, M. & Staye, J. (1982) Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine. American Journal of Psychiatry, 139, 1178-1180.
  6. * Gualtieri, C.T., Quade, D., Hicks, R.E. & Schroeder, S.R. (1984) Tardive dyskinesia and the clinical consequences of neuroleptic treatment in children and adolescents. American Journal of Psychiatry, 141, 21-23. Abstracted in Psychiatry Digest.
  7. Gualtieri, C.T. & Sprague, R.L. (1984) Preventing tardive dyskinesia and preventing tardive dyskinesia litigation. Psychopharmacology Bulletin, 20(3), 346-348.
  8. Gualtieri, C.T. (1985) The Problem of Tardive Dyskinesia Litigation. Psychiatric Aspects of Mental Retardation Reviews, 4(4), 12-16, April.
  9. Schroeder S.R. & Gualtieri, C.T. (1985) Behavioral interactions induced by chronic neuroleptic therapy in persons with mental retardation. Psychopharmacology Bulletin, 21, 310-315.
  10. Gualtieri, C.T., Keppel, J.M. & Schroeder, S.R. (1986) Tardive Dyskinesia: New Facts and New Recommendations. Psychiatric Aspects of Mental Retardation Reviews, 5(1), 1-6.
  11. * Gualtieri, C.T., Schroeder, S.R., Hicks, R.E. & Quade, D. (1986) Tardive dyskinesia in young mentally retarded individuals. Archives of General Psychiatry, 43, 335-340.
  12. * Gualtieri, C.T. & Patterson, D.R. (1986) Neuroleptic-Induced Tics. American Journal of Psychiatry, 143(9), 1176-1177.
  13. * Gualtieri, C.T., Sprague, R.L., Cole, J.O. & Liption, M.A. (1986) Tardive dyskinesia litigation & the dilemmas of neuroleptic treatment. The Journal of Psychiatry and the Law, 14(1-2), 187-216.
  14. American Psychiatric Association (1992) Task Force Report on Tardive Dyskinesia. American Psychiatric Press, Washington.
  15. Gualtieri, C.T. & Barnhill, L.J. (1988) Tardive Dyskinesia in Special Populations. In: M. Wolf (ed), Biological Mechanisms & Clinical Aspects, American Psychiatric Press, Washington. pp 137-54.
  16. Richmond, G., Bell, J., Brown, D.K., Kissel, R.C., Gualtieri, C.T. & Schroeder, S.R. (1987) Changes in Severity of Tardive Dyskinesia in the Retarded During Follow-up Neuroleptic Withdrawal. (Unpub)
  17. Gualtieri, C.T. & Sovner, R.M. (1989) Tardive Akathisia. Psychiatric Aspects of Mental Retardation Reviews, 8, 83-90.
  18. Gualtieri, C.T. (1991) TMS: A system for Prevention and Control. In J Ratey (Ed), Mental Retardation: Developing Pharamcotherapies, American Psychiatric Press, Washington, pp 35-50.
  19. * Gualtieri, C.T., N. Sanders, and N. Leslie. (1993). The problem of tardive akathisia. Brain and Cognition, 23, 102-109.
  20. Gualtieri, C.T., N. Leslie, and N. Sanders. 1993. Tardive Akathisia: Prevalence and Validation. (UnPub)

Psychopharmacology

  1. * Gualtieri, C.T. (1977) Imipramine and children: A review and some speculations on the mechanism of drug action.Diseases of the Nervous System, 38, 368-375.
  2. * Gualtieri, C.T. & Powell, S.F. (1978) Psychoactive drug interactions. Journal of Clinical Psychiatry, 39, 720-729.
  3. * Gualtieri, C.T. & Staye, J. (1979) Withdrawal symptoms after abrupt cessation of amitryptiline in an eight-year old boy. American Journal of Psychiatry, 136, 1201-1203.
  4. * Linoilla, M., Gualtieri, C.T. & Jobson, J. (1980) Therapeutic characteristics of imipramine response in hyperactive children. Journal of American Academy of Child and Adolescent Psychiatry, 19, 491-510.
  5. Gualtieri, C.T. & Hawk, B. (1981) Clinical guide to pediatric psychopharmacology. In: S. Gabel (ed), Behavioral Problems in Childhood. New York: Gune & Stratton, pp. 409-424.
  6. Gualtieri, C.T. & Hawk, B. (1982) Antidepressant drugs and lithium salts in the treatment of the mentally retarded. In: S. Breuning & A.D. Poling (eds), Drugs and Mental Retardation. New York: Charles C. Thomas Press, pp. 215-234.
  7. * Gualtieri, C.T., Golden, R. & Fahs, J. (1983) New developments in pediatric psychopharmacology. Journal of Developmental and Behavioral Pediatrics, 4, 202-208.
  8. Golden, R.N. & Gualtieri, C.T. (1983) Clinician's guide to the new antidepressants. Resident & Staff Physician, 29, 65-72. Reprinted in Medical Times, 111, 101-107.
  9. * Gualtieri, C.T., Golden, R. Wargin, W. & Breese, G. (1984) Blood level measurement of psychoactive drugs in pediatric psychiatry, Therapeutic Drug Monitoring, 6, 127-141.
  10. * Evans, R.W. & Gualtieri, C.T. (1985) Carbamazepine: A Neuropsychological & Psychiatric Profile. Clinical Neuropharmacology, 8(3), 221-241.
  11. * Evans, R.W., Clay, T. & Gualtieri, C.T. (1987) Carbamazepine in Pediatric Psychiatry. Journal of American Academy of Child and Adolescent Psychiatry, 26(1), 2-8. Abstracted in Psychiatry Digest, (1987) 5, 11-12. Reprinted in the Yearbook of Psychiatry and Applied Mental Health.
  12. Evans, R.W., Amara, I. & Gualtieri, C.T. (1986) Piracetam and Memory Functions: Preliminary Negative Findings. (Unpub)
  13. * Evans, R.W. & Gualtieri, C.T. (1988) Motor Performance in Hyperactive Children Treated with Imipramine. Perceptual and Motor Skills, 66, 763-769.
  14. Clay, T.H., Guillon, C.M., Gualtieri, C.T. & Evans, R.W. (1988) Clinical and Neuropsychological Effects of the Novel Antidepressant, Bupropion. Psychopharmacology Bulletin, 24(1), 143-148.
  15. Gualtieri, C.T. (1991). Paradoxical effects of fluoxetine. J Clin Psychopharmacol, 11, 393-394.
  16. Gualtieri,C.T., Bach-y-Rita,P.R. (1997). Non-synaptic Diffusion Neurotransmission: Mood, Fuzzy Logic and Drug Effects. Ms submitted.

Neuropsychiatry / Neuropsychology

  1. * Hicks, R.E., Schroeder, S.R. & Gualtieri, C.T. (1982) Effects of response language and stiumuls context upon judgements of visual and temporal extent. American Journal of Psychology, 96, 382-384.
  2. * Hicks, R.E., Gualtieri, C.T. & Schroeder, S.R. (1983) Cognitive and motor components of bilateral transfer. American Journal of Psychology, 96, 365-375.
  3. * Hicks, R.E., Perez-Reyes, M., Mayo, J.P. & Gualtieri, C.T. (1984) Cannabis, Atropine and Temporal Information Processing. Neuropsychobiology, 12, 229-237.
  4. * Evans, R.W., Ruff, R.M. & Gualtieri, C.T. (1985) Verbal Fluency & Figural Fluency in Bright Children. Perceptual Motor Skills, 61, 699-709.
  5. * Hicks, R.E., Kinsbourne, M. & Gualtieri, C.T. (1985) Response processes in judgmental contrast. Journal of General Psychology, 112, 79-89.
  6. * Evans, R.W., Gualtieri, C.T. & Ruff, R.M. (1986) Alternative Selective Reminding Forms for Children. Developmental Neuropsychology, 2(2), 137-144.
  7. * Evans, R.W., Gualtieri, C.T. & Patterson, D.R. (1986) Treatment of Chronic Closed Head injury with Psychostimulant Drugs: A Controlled Case Study and An Appropriate Evaluation Procedure. Journal Nervous & Mental Disease, 175(2), 106-110.
  8. * Evans, R.W. & Gualtieri, C.T. (1987) Psychostimulant Pharmacology in Traumatic Brain Injury. Journal of Head Trauma Rehabilitation, 2(4), 29-33.
  9. * Gualtieri, C.T. (1988) Pharmacotherapy and the Neurobehavioral Sequelae of Traumatic Brain Injury. Brain Injury, 2(2), 101-129.
  10. Gualtieri, C.T. & Evans, R.W. (1988) Stimulant Treatment of Closed Head Injury Patients: Controlled Trial. Brain Injury, 2, 273-290.
  11. * Barnhill, L.J. & Gualtieri, C.T. (1989) Late-Onset Psychosis Following Head Injury. Neuropsychiatry, Neuropsychology & Behavioral Pharmacology, 2, 211-218, 1989.
  12. * Chandler, M.C., Barnhill, L.J., Gualtieri, C.T. (1988) Amantadine for the Agitated Head-Injury Patient. Brain Injury, 2(4), 309-311.
  13. Gualtieri, C.T., Nygard, N.K. (1988) Rehabilitation of 'Poor Prognosis' Head Injuries. Rebound Quarterly Research Report, 1(2), 4-5.
  14. Gualtieri, C.T., Evans, R.W. (1988) Use of a Stimulant with Brain Injured Clients. Rebound Quarterly Research Report, 1(2), 6-8.
  15. Gualtieri, C.T., Nygard, N.K. (1988) Rehabilitation for Head Injury, Five Years after the Event. Rebound Quarterly Research Report, 1(2), 16-26.
  16. Gualtieri, C.T., Nygard, N.K. (1988) Stimulant Treatment for the Neurobehavioral Sequelae of Traumatic Brain Injury. Rebound Quarterly Research Report, 1(2), 27-40.
  17. * Gualtieri, C.T., Chandler, M.L., Coons, T., & Brown, L. (1989) Amantadine: A New Clinical Profile for Traumatic Brain Injury. Journal of Clinical Neuropharmacology, 12, 258-270.
  18. Gualtieri, C.T. (1991) Psychostimulants in Traumatic Brain Injury. In L. Greenhill & B.B. Osman (Eds), Ritalin: Theory and Patient Management, Mary Ann Liebert, New York, pp 171-176.
  19. * Gualtieri, C.T. (1991) Buspirone. Journal of Head Injury Rehabilitation, 6:90-92.
  20. * Gualtieri, C.T. (1990) Inadvertent Drug Effects in Traumatic Brain Injury, Journal of Head Injury Rehabilitation, 5:32-40.
  21. * Gualtieri, C.T. 1990. The neuropsychiatric sequelae of traumatic brain injury. Journal of Child and Adolescent Psychopharmacology 1:149-152.
  22. * Gualtieri,C.T. & Cox, D. (1991) Delayed Neurobehavioral Sequellae of Traumatic Brain Injury. Brain Injury 5:219-232.
  23. * Blackerby, W.F., and C.T. Gualtieri. 1991. Recent advances in neurobehavioral rehabilitation. NeuroRehabilitation 1:53-61.
  24. * Gualtieri, C.T. 1991. Buspirone for the behavior problems of patients with organic brain disorders. J Clin Psychopharmacol 11:280-281.
  25. Gualtieri, C.T. 1991. Buspirone for the neurobehavioral sequelae of temporal lobe injuries. (UnPub)
  26. * Arcia, E., and C.T. Gualtieri. (1994). Neurobehavioral performance of patients with closed head injury, attention deficit, and controls. Brain Injury, 8, 395-404.
  27. Gualtieri, C.T. (1993). Pharmacological interventions for Cognitive and behavioral impairments. In Brain Injury Rehabilitation: Clinical Considerations. M.A.J. Finlayson, and S. Garner, editors. Williams & Wilkins, Baltimore. pp 264-278.
  28. * Arcia, E., and C.T. Gualtieri. (1993). Association between patient report of symptoms after mild head injury and neurobehavioral performance. Brain Injury 7, 481-489.
  29. Gualtieri, C.T. 1993. Traumatic Brain Injury. In Principles of Medical Psychiatry, 2nd Ed. A. Stoudemire, and B. Fogel, editors. Oxford University Press, New York. pp 517-538.
  30. Blackerby,W.F., Gualtieri, C.T.,. (1991). Recent advances in neurobehavioral rehabilitation. NeuroRehabilitation 1, 53-61.
  31. Gualtieri, C.T. (1991) The functional Neuroanatomy of Psychiatric Treatments. Psychiatric Clinics of North America 14, 113-124.
  32. Gualtieri,C.T. (1995). The contribution of the frontal lobes to a theory of psychopathology. In Neuropsychiatry of Personality Disorders, Ed J.J.Ratey. Blackwell Science, Cambridge, 1995. pp 149-171.
  33. * Gualtieri,C.T. (1995). The problem of mild brain injury. Neuropsychiatry, Neuropsychology and Behavioral Neurology, 8, 127-136.
  34. Gualtieri,C.T. (1999). The treatment of mild brain injury. In Mild Brain Injury. N Varney, ed.
  35. Gualtieri,C.T., Johnson,L.G. (1999). Problems in neuropsychiatric and neuropsychological assessment. Neurorehabilitation, in press.

Mental Retardation, Developmental Disabilities

  1. Gualtieri, C.T. (1979) Psychiatry's disinterest in mental etardation. Psychiatric Opinion, 16, 26-30.
  2. * Gualtieri, C.T., Koriath, J., Van Bourgondien, M. & Saleeby, N. (1983) Language disorders in children referred for psychiatric services. Journal American Academy Child Psychiatry, 22, 165-171.
  3. * Gualtieri, C.T., Koriath, U. & Van Bourgondien, M.D. (1983)'Borderline' Children. Journal of Autism & Developmental Disabilities, 13, 67-72. Abstracted in Digest of Neurology & Psychiatry, 1983, LI, 210.
  4. * Gualtieri, C.T. & Keppel, J.M. (1985) Psychopharmacology in the Mentally Retarded and a Few Related Issues. Psychopharmacology Bulletin, 21(2), 304-309.
  5. Gualtieri, C.T. (1986) Fenfluramine & Autism: A Careful Re-Appraisal is in Order. Journal of Pediatrics, 108(3), 417-419.
  6. Schroeder, S.R., Gualtieri, C.T. & Van Bourgondien, M.E. (1986) Autism. In: M. Hersen (ed) Pharmacological and Behavioral Treatment: An Integrative Approach. New York: Wiley, pp. 89-107.
  7. Gualtieri, C.T., Evans, R.W. & Patterson, D.R. (1987) The Medical Treatment of Autistic People: Problems and Side Effects. In: E. Schopler & G. Mesibov (eds) Neurobiological Issues in Autism. New York: Plenum Press, 373-388.
  8. Gualtieri, C.T. (1988) The Mental Health of Retarded People: A Solution, Obstacles to the Solution, and Resolution for the Problem. In: J. Stark, F. Menolascino, M. Albarelli & V. Gray (eds) Mental Health and Mental Retardation: Classification, Diagnosis, Treatment, Services. New York: Springer Verlag, pp. 173-188.
  9. * Gualtieri, C.T. & Schroeder, S.R. (1989) Pharmacotherapy for Self-Injurious Behavior: Preliminary Tests of the D1 Hypothesis. Psychopharmacology Bulletin, 25, 364-371, 1989.
  10. * Gualtieri,C.T. (1989) Differential Diagnosis of Self-Injurious Behavior. Psychopharmacology Bulletin, 25, 359-363.
  11. Gualtieri, C.T. (1990) Neuropsychiatric Treatment for Autistic People. Post Graduate Advances in Autism, Forum Medicum. pp 1-11.
  12. Chandler, M., Barnhill, L.J. & Gualtieri, C.T. (1991) Amantadine: A medical, Neuropsychological and Psychiatric Profile. In J Ratey, Mental Retardation: Developing Pharmacotherapies, American Psychiatric Press, Washington, pp 139-162.
  13. Gualtieri,C.T. (1990) Pharmacotherapy for Self-Injurious Behavior: Preliminary Tests of the D1 Hypothesis. Progress Neuro-Psychopharmacol Biol, 14 (Suppl): S81-107.
  14. * Gualtieri, C.T., Van Bourgondien, M.E., Hartz, C., Schopler, E., Marcus, L. (1980) A Pilot Study of Pyridoxine in Autistic Children. (Unpub).
  15. * Gualtieri, C.T. 1991. The measurement of self-injurious behavior. J Neuropsych 3:s30-s34.
  16. Ratey, J.J., and C.T. Gualtieri. 1991. Neuropsychiatry and mental retardation. In Mental Retardation: Developing Pharmacotherapies. J.J. Ratey, editor. American Psychiatric Press, Washington,D.C.. 1-18.
  17. * Gualtieri, C.T. 1992. Psychopharmacology and the Fragile X Syndrome. In 1992 International Fragile X Conference Proceedings. R.J. Hagerman, and P. McKenzie, editors. Spectra Publishing Company, Dillon, Colorado. 167-178.
  18. Gualtieri, C.T. (1992). New approaches to psychopharmacology for autistic people. Rev Ital Disturb Intell 5, 127-136. Italian translation, pp 165-174.
  19. Casner,J., Weinheimer,B., Gualtieri,C.T. (1995). Naltrexone and self-injury: a retrospective population study. J Clin Psychopharm, 16, 389-394, 1996.
  20. Fitzpatrick-Sanchez, S, Williams, D.E., Gualtieri, C.T., Raichman,J.A.. (1997). The effects of selective serotonergic reuptake inhibitors combined with behavioral treatment for self-injury associated with the Lesch-Nyhan syndrome. J Dev Phys Disabilities 10, 283-290, 1998.

Immunoreactivity

  1. * Gualtieri, C.T., Hicks, R.E. & Mayo, J.P. (1984) Influence of Sex of Antecedent Siblings on the Human Sex Ratio. Life Sciences, 34, 1791-1794. Reprinted in 1984 in Obstetrics and Gynecology.
  2. * Gualtieri, C.T. & Hicks, R.E. (1985) The Immunoreactive Theory of Selective Male Affliction. Behavior and Brain Sciences, 8(3), 427-477.
  3. * Gualtieri, C.T., Mayo, J.P. & Hicks, R.E. (1985) ABO Incompatibility and Parity Effects of Perinatal Mortality. Social Biology, 32(1-2), 129-131.
  4. * Gualtieri, C.T. & Hicks, R.E. (1986) Family Configuration and Family Size. Social Biology 33(1-2), 146-147.
  5. Gualtieri, C.T. (1987) Fetal Antigenicity & Maternal Immunoreactivity in the Genesis of Mental Retardation. In: S.R. Schroeder (ed) Toxic Substances and Mental Retardation: Neurobehavioral Toxicity & Teratology, Washington, DC: AAMD Monograph Series, pp. 33-67.

Other Areas

  1. Rosman, A.W. & Gualtieri, C.T. (1980) Therapeutics bibliography for clinical pharmacists: Psychiatry. American Journal Hospital Pharmacy, 37, 860-862.
  2. * Gualtieri, C.T., Adams, A., Shen, C.D. & Loiselle, (1982) Minor physical anomalies in alcoholic and schizophrenic adults. American Journal of Psychiatry, 139, 640-642.
  3. * Alhadeff, L., Gualtieri, C.T. & Lipton, M.A. (1984) Toxic Effects of Water Soluble Vitamins. Nutrition Reviews, 42, 33-40.
  4. Gualtieri, C.T., Chandler, M.C. & Barnhill, L.J. (1990) Assessment of Physical Status: The Neuropsychiatric Examination of the Child. In: G. Burrows, B. Tonge & J. Werry (eds) Handbook of Studies in Child Psychiatry, Elsevier, Amsterdam

Presentations

  1. American Psychiatric Association, 1981, 1982, 1985, 1986, 1990
  2. American Psychological Association, 1980
  3. American College of Neuropsychopharmacology, 1983, 1988
  4. American Academy of Child Psychiatry, 1983, 1984, 1985, 1986, 1987
  5. American Association of Psychiatric Services for Children, 1977, 1981
  6. International Neuropsychological Society, 1987, 1989
  7. New York Orton Society, 1984
  8. International Conference on Psychiatry and the Law, 1984
  9. National Conference on Research in Mental Retardation (Gatlinburg), 1986
  10. American Association for Mental Deficiency, 1983
  11. NIMH Consensus Conferences, 1979, 1984(2)
  12. New Clinical Drug Evaluation Unit, 1983, 1986
  13. President's Committee on Mental Retardation, 1985
  14. World Psychiatric Association, 1986
  15. National Association for the Dually Diagnosed, 1988
  16. Cornelia de Lange Foundation (annually) 1988-

 
Neurocognitive Testing
CNS Vital Signs™

Finally ... an easy-to-use, in-office computerized neurocognitive testing procedure. Click to Learn More.